# 1008, Columbia University — New York, New York

# 1008, Columbia University is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

# 1008, Columbia University has participated in 2 clinical trials.

Therapeutic areas: Adult Solid Tumor, Advanced Solid Tumor.

Sponsors: Debiopharm International SA, Repare Therapeutics.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for # 1008, Columbia University?

# 1008, Columbia University has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has # 1008, Columbia University conducted?

# 1008, Columbia University has 2 clinical trials on record. Their work covers Adult Solid Tumor, Advanced Solid Tumor.

Is # 1008, Columbia University accredited by Crixeo Health?

# 1008, Columbia University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about # 1008, Columbia University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.